Alclometasone Dipropionate 66734-13-2
Alclometasone is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent. Alclometasone Dipropionate marketed as medication Aclovate by GlaxoSmithKline.
Pharmacology
Alclometasone inhibits phospholipase A2 by inducing production of lipocortins; inhibits synthesis of arachidonic acid, prostaglandins and leukotrienes acid, reduce release of cytokines from lymphocytes and others mediators of inflammation (incl. histamine).
Indications
Alclometasone cream and onintment are indicated forthe relief of corticosteroid-responsive dermatoses, including:
- atopic dermatitis
- eczema
- psoriasis
- allergic dermatitis
- contact dermatitis
- actinic dermatitis
- kiss-type allergy
- skin itch
Alclometasone may be used on sensitive skin sites (face, skinfolds); in pediatric patients 1 year orolder and in geriatric patients.
Contraindications
Side effects
Alclometasone Adverse reactions/Side effects (sometimes, less than 1-2% cases) include:
- burning
- itching
- erythema
- skin reddening
- xerodermia
- skin irritation
- acne
- hypopigmentation
- prickly heat
- folliculitis
- white atrophy
- hypertrichosis
- reinfection of skin
How supplied
Alclometasone as Aclovate is supplied in:
- Cream; Topical; 0. 05%
- Ointment; Topical; 0. 05%
| Systematic (IUPAC) name: | [7-chloro-11-hydroxy- 10,13,16-trimethyl-3-oxo-17- (2-propanoyloxyacetyl)- 7,8,9,11,12, 14,15,16- octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate |
|---|---|
| Alclometasone Dipropionate CAS number: | 66734-13-2 |
| ATC code: | D07AB10 |
| PubChem: | 5311000 |
| DrugBank: | APRD00783 |
| Formula: | C28H37ClO7 |
| Molecular mass: | 521.05 g/mol |
| Alclometasone Dipropionate Assay/Purity: | Typically NLT 98% |








